Related Experiment Video
Updated: May 6, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
A Road Map to Understanding Cardiovascular Disease in Diabetes: From the AHA Strategically Focused Research Network
E Dale Abel1, Rexford S Ahima2, Ethan J Anderson3
1Department of Medicine, David Geffen School of Medicine, University of California Los Angeles (E.D.A.).
Insights
Patients with diabetes face a doubled risk of cardiovascular issues. Research networks are investigating the underlying mechanisms and seeking new biomarkers to predict and prevent these serious heart complications.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Metabolic Diseases
Background:
- Diabetes mellitus (type 1 and type 2) significantly elevates cardiovascular complication risk.
- Despite advances, the mechanisms linking diabetes to heart disease remain incompletely understood.
- Atherosclerotic cardiovascular disease and heart failure are major concerns in diabetic populations.
Purpose of the Study:
- To review current research on why diabetes accelerates atherosclerotic cardiovascular disease and heart failure.
- To integrate findings from the Strategically Focused Research Network on Cardiometabolic Health and Type 2 Diabetes.
- To identify novel risk factors and suggest future research directions.
Main Methods:
- Review of basic, translational, and clinical studies.
- Analysis of human population data for biomarker discovery.
- Consideration of experimental models (cell and animal studies).
- Integration of findings from four leading research centers.
Main Results:
- Diabetes confers over a 2-fold increased risk of cardiovascular complications.
- Ongoing research aims to uncover novel disease mechanisms and prognostic biomarkers.
- Human data and experimental models provide complementary insights into diabetes-driven heart disease.
Conclusions:
- Understanding the link between diabetes and cardiovascular disease requires multifaceted research approaches.
- Identifying new risk factors and biomarkers is crucial for improved patient outcomes.
- Continued investigation into cardiometabolic health in diabetes is essential for prevention and treatment strategies.
Abstract:
Despite major advances in medical therapies and prevention strategies, the risk of cardiovascular complications in patients with both type I and type II diabetes remains substantially elevated. In 2019, the American Heart Association sought applications for a Strategically Focused Research Network on Cardiometabolic Health and Type 2 Diabetes. In 2020, 4 centers were named, including Brigham and Women's Hospital, Johns Hopkins University, New York University, and the University of Iowa. These centers performed basic, translational, and clinical studies to provide insights to explain the over 2-fold risk of cardiovascular complications in diabetes. Clinical studies and studies in cells and animals aimed to uncover new mechanisms responsible for disease development. Studies using human populations sought to uncover new biomarkers to prognosticate risk. In this review, we discuss several key issues and current and developing methods to understand why diabetes drives atherosclerotic cardiovascular disease and heart failure. Both human data and experimental models are considered. We integrate a review of these topics with work from the Strategically Focused Research Network and conclude with suggestions for identifying novel risk factors and future experimental research.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Coronary Artery Disease I: Introduction
Atherosclerosis IV: Nursing Management
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Diabetic Retinopathy

